Navigation Links
U of M research finds disordered eating less common among teen girls who regularly eat family meals
Date:1/8/2008

MINNEAPOLIS / ST. PAUL (Jan. 8, 2008) Adolescent girls who frequently eat meals with their families appear less likely to use diet pills, laxatives, or other extreme measures to control their weight five years later, according to research led by Dianne Neumark-Sztainer, Ph.D., M.P.H., R.D., lead investigator of Project Eating Among Teens (Project EAT) at the University of Minnesota School of Public Health.

Neumark-Sztainer and Project EAT colleagues studied 2,516 adolescents at 31 Minnesota schools over the course of five years. Participants completed two surveysan in-class survey in 1999 and a mailed survey in 2004regarding how often they ate with their families as well as their body mass index, feelings of family connectedness, and eating behaviors.

Among teen girls, those who ate five or more meals with their families each week in 1999 were significantly less likely to report using extreme measuresincluding binge eating and self-induced vomitingto control their weight in 2004, regardless of their sociodemographic characteristics, body mass index, or family connectedness. Among adolescent boys, regular family meals did not predict lower levels of disordered eating behaviors five years later.

The reasons for the gender differences are unclear. Boys who engage in regular family meals may be different in some way that increases their risk for disordered eating behaviors. It is also possible that adolescent boys and girls have different experiences at family meals. For example, girls may have more involvement in food preparation and other food-related tasks, which may play a protective role in the development of disordered eating behaviors. Girls also may be more sensitive to, and likely to be influenced by, interpersonal and familial relationships present at family meals than adolescent boys.

Given the findings of this and other studies and the prevalence of disordered eating among teen girls, the researchers conclude that it
'/>"/>

Contact: Laura Stroup
stro0481@umn.edu
612-624-5680
University of Minnesota
Source:Eurekalert

Page: 1 2

Related biology news :

1. Leading researchers and experts gather to discuss latest advancements in drug discovery
2. Oncolytics Biotech, Inc. announces publication of research
3. Electrospray droplet research yields surprising, practical results
4. Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers
5. Researchers uncover key trigger for potent cancer-fighting marine product
6. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
7. LSU and Ohio State battle on football field, collaborate in research field
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. Research explores role of hydrogen peroxide in cell health
10. Cornell researchers prove how plants transport sugars
11. Cornell researcher seeks clues to how tuberculosis infects cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...already spurred public health officials to advise ...ing concern in a warmer world. , So suggests a p... Oecologia . , Sue Natali, a postdoctoral assoc...e paper,s lead author, compared mercury levels in ...bon dioxide to soil beneath trees in ambient air. ...
(Date:1/7/2009)...l issue of American Journal of Medical Genetics (... a comprehensive overview of the latest progress i...ity Disorder (ADHD). The issue covers major trends...erscoring how genetic studies of ADHD have evolved...netic origins. , ADHD is a complex condition wit...
(Date:1/7/2009)...sed to low temperatures develop more blood vessels...ore quickly, according to a new study from Karolin...o control blood vessel development in humans in or... of fat cells and their metabolism depend on oxyge...ulate the amount of body fat in order, for instan...
(Date:1/7/2009)... , A PhD thesis at the University of the Bas...e mutation that causes Fatal Familiar Insomnia (FF...try there is a high rate of carriers of this mutat...f Spain. , Fatal Familiar Insomnia (FFI) is o...ess than 100 cases described throughout the world....
Breaking Biology News(10 mins):To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3Studies examine genetic determinants of ADHD 2Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3Standard 26 Poors Announces Changes to U S Indices 22973 1Standard 26 Poors Announces Changes to U S Indices 22973 2Standard 26 Poors Announces Changes to U S Indices 22973 3Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 1Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 2Genmab Reaches Milestone in Ofatumumab Collaboration 2556 1Genmab Reaches Milestone in Ofatumumab Collaboration 2556 2Caffeine Could Stave Off Multiple Sclerosis 22968 1Caffeine Could Stave Off Multiple Sclerosis 22968 2
...tween researchers at the Salk Institute for Biolog...os Angeles captured the genome-wide DNA methylatio..."laboratory rat" of the plant world - in one big s... 20 years worth of anecdotal findings and then som...essor in the Salk Institute,s Plant Biology Labora...
...ns one of the deadliest threats to public health. ... which is caused by the microorganism Mycobacteriu...opulation is infected and more and more bacterial ...chers from the Hamburg Outstation of the European ...anck Institute for Infection Biology (MPIIB) in Be...
...versity research group has discovered that aggress...s critical to proper embryo formation. , An arti...n the advanced online issue of the journal Nature ...d highly unstable embryonic growth factor by injec...rafish embryos, which were used as "biosensors" fo...
...rs have discovered that the human immunodeficiency...vive efforts to destroy it by hiding out in the mu...at HIV continues to replicate in the gut mucosa, s...ed with antiretroviral therapy--even when blood sa...tment was working. Results of the three-year study...
Other Biology News:In a technical tour de force, Salk scientists take a global view of the epigenome 2In a technical tour de force, Salk scientists take a global view of the epigenome 3New potential drug target in tuberculosis 2Malignant melanoma cells secrete protein required for embryo formation 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 3
(Date:1/8/2009)... SAN DIEGO, Jan. 8 Orex...y announced that the first of four Phase 3 trials ...naltrexone sustained release,(SR)/bupropion SR) m...wing a,significant reduction in body weight, impr...ductions in selected food craving measures. , ...
(Date:1/8/2009)... REDWOOD CITY, Calif., Jan. 8 Ace...hired Dr. Roman Skowronski as Vice President, Clin...ronski will be responsible for,development and ex...l input,and review of clinical development strate...pany,s Chief Medical Officer. , Prior to jo...
(Date:1/8/2009)... HUNTINGTON BEACH, California, and AMSTERDAM, Jan... molecular cancer diagnostics, today announced the...mpany,s new Chief Financial,Officer. , "Ku...nvaluable asset,",said Bernhard Sixt, Ph.D., Pres...nsive financial management experience in the high ...
(Date:1/8/2009)...ERDEEN PROVING GROUND, Md., Jan. 8 ... anthrax attacks that followed, Edgewood Chemical ...ring Laboratory (EBML) staff focuses on developing...rld demands for global accreditation, increased se...y control. , , "We continue to work towards con...
Breaking Biology Technology:Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7Agendia Appoints New Chief Financial Officer 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 3
... A few years ago, a VC friend of mine (that had ...repeatedly about a concept that was gathering forc...ction, in this case, meaning the casting away of p...ened to him and agreed, I didn,t recognize this mo...ing. The problem, as recognized by a recent articl...
... The transition from Microsoft Windows XP to ...the cultural transition we,ve already made from We...ly coined the term Web 2.0 in 2004, the Internet ... he imagined: a place where people are. It has bec...where we collaborate with others. It has also beco...
... West Allis, Wis. - Merge Healthcare , a financ...formation management software, continued to revamp...Bowers to president of Merge Healthcare North Amer...y,s senior vice president of strategic business in... Kenneth D. Rardin. In his new position, Bowers wi...
... Madison, Wis. - Molly Jahn is a realist, and sh...has a realistic chance to lead the drive toward en...f the College of Agricultural and Life Sciences ...ahn believes Wisconsin can leverage existing econo...uels. , ,She,s well aware of criticism that Wiscon...
Other Biology Technology:The deconstruction of Big Pharma 2The deconstruction of Big Pharma 3The deconstruction of Big Pharma 4The deconstruction of Big Pharma 5The deconstruction of Big Pharma 6The deconstruction of Big Pharma 7The deconstruction of Big Pharma 8Making the transition from Web 2.0 to Web 2.007 2Making the transition from Web 2.0 to Web 2.007 3UW-Madison dean predicts bio-economy will fuel Wisconsin 2UW-Madison dean predicts bio-economy will fuel Wisconsin 3
mCD-1 10 transcription reactions
Rabbits x 2 , Maintenance 112 days/each , Pre-immune bleed x1 /each , Immunizations/Boost injections x5 /each , Test bleed (app. 5 ml) x1 /each , Production bleed (25 ml blood =12 m
Mouse VCAM-1/CD106 MAb (Clone 112702)
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*
Biology Products: